4Holvoet P, Bucolo G, Wieland O et al. Oxidized LDL and malondialdehyde - modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation,1998; 98 (15): 1487-1494. 被引量：1
5Kohno H, Wang XL, Pullinger CR et al. Simple and practical sandwich- type enzyme immunoassay for human oxidatively modified low density lipoprotein using anti - oxidized phosphatidylclaoline rnonoclonal antibody and antihuman apolipoprotein-B antibody. Clin Biochem, 2000; 33 (4): 243-253. 被引量：1
6Toshima S,Kume N,Cushing SD et al.Circulating oxidized low density lipoprotein levels.A biochemical risk marker for coronary heart disease.Arterioseler Thromb Vasc Biol,2000；20(9):2243-2274. 被引量：1
7Gardner G, Lehmann JM, Nakata Met al. Modified LDL-mediated increases in endothelial layer permeability are attenuated with 17 beta - estradiol. Arterioscler Thromb Vasc Biol,1999; 19 (4): 854-861. 被引量：1
8Ziouzenkova O, Ageta M, Wiebe DA et al. Oxidative crosslinking of ApoB100 and hemoglobin results in low density lipoprotein modification in blood. Relevance to atherogenesis caused by henmodialysis. J Biol Chem, 1999; 274 (27):18916- 18924. 被引量：1
9Holvoet P, Nakamura T, Vague J et al. Oxidized low density lipoprotein is a prognostic marker of transplant - associated coronary artery disease. Arterioscler Thromb Vasc Biol, 2000;20 (3): 698-702. 被引量：1
10Grundy SM, Howard B, Smith S, et al. Prevention Conference Ⅵ: Diabetes and Cardiovascular Disease: executive summary: conference proceeding for healthcare professionals from a special writing group of the American Heart Association. Circulation,2002, 105:2231-2239. 被引量：1
9Qureshi G, Brown R, Salciccioli L, et al. Relationship be- tween aortic atherosclerosis and non-invasive measures of ar- terial stiffness [ J ]. Atherosclerosis, 2007,195 (2) : el 90-e194. 被引量：1
10Cohn J N, Duprez D A, Grandits G A. Arterial elasticity as part of a comprehensive assessment of cardiovascular risk and drug treatment[ J]. Hypertension, 2005,46( 1 ) :217-220. 被引量：1
